Afluria Pregnancy Registry
NCT03442582 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 490
Last updated 2022-02-09
Summary
The study is a population based prospective cohort study designed to collect data on pregnancy outcomes and events of interest among women immunized with Afluria during pregnancy.
Conditions
- Influenza, Human
- Pregnancy
- Birth Defect
Interventions
- BIOLOGICAL
-
Afluria Influenza Vaccine
Afluria is a seasonal influenza vaccine Vaccine exposure in routine care (no vaccination per protocol)
Sponsors & Collaborators
-
Seqirus
lead INDUSTRY
Principal Investigators
-
Head Epidemiology · Seqirus
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-09-08
- Primary Completion
- 2021-09-14
- Completion
- 2021-09-14
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Response to Influenza Vaccine During Pregnancy
NCT03888989 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above
NCT00345904 ·Status: COMPLETED ·Phase: PHASE3
-
Brief Influenza Vaccine Education to Pregnant Women
NCT01772901 ·Status: COMPLETED ·Phase: NA
-
Sanofi Pasteur Quadrivalent Intradermal Influenza Vaccine Pregnancy Registry
NCT02554409 ·Status: COMPLETED
-
Evaluate the Immunogenicity and Safety of the 2011-2012 Vaccine Against Seasonal Influenza on Pregnant Women
NCT01577316 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their Offspring
NCT04460781 ·Status: COMPLETED
-
Safety of H1N1 Influenza Vaccination in Pregnant Women
NCT01842997 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women
NCT01024400 ·Status: COMPLETED ·Phase: PHASE2
-
A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women
NCT01354730 ·Status: COMPLETED
-
H1N1 Vaccine in Pregnancy: a Registry for the Fall and Winter of 2009
NCT01374009 ·Status: TERMINATED
-
A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults
NCT00920374 ·Status: COMPLETED ·Phase: PHASE3
-
Novartis H1N1 Vaccine in Pregnant Women
NCT00992719 ·Status: COMPLETED ·Phase: PHASE2
-
Field Trial of Maternal Influenza Immunization in Asia
NCT01034254 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pregnants
NCT01218685 ·Status: COMPLETED
-
Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults
NCT00386698 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya
NCT01810731 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Influenza Vaccine Postpartum Questionnaire
NCT00401700 ·Status: COMPLETED
-
VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old
NCT00973895 ·Status: COMPLETED ·Phase: PHASE1
-
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women
NCT07211152 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults
NCT01144299 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of RIV4 Versus IIV4 in Pregnant Women
NCT03969641 ·Status: COMPLETED ·Phase: PHASE4
-
H1N1 Vaccine in Pregnant Women
NCT00963430 ·Status: COMPLETED ·Phase: PHASE2
-
Opting In vs Opting Out
NCT01233804 ·Status: COMPLETED ·Phase: NA
-
Study of Immune Responses to Influenza Vaccination
NCT03346772 ·Status: RECRUITING ·Phase: PHASE4
-
Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study
NCT01037829 ·Status: COMPLETED